Aims: The control of Salmonella in pig production is necessary for public and animal health, and vaccination was evaluated as a strategy to decrease pig prevalence.
Introduction
The 2015 European summary report on food-borne outbreaks reported that Salmonella was responsible for the majority (21Á8%) of food-borne outbreaks in the European Union (EU) (EFSA 2016) . It is estimated that 13% of outbreaks are associated with pig meat and products thereof (EFSA 2016) . Pork is considered, after eggs, the major source of infection in humans in the EU, with S. Typhimurium (ST) including monophasic strains (S. 1,4, [5] ,12:i-and S. 1,4,12:i-) being frequently implicated (Andres and Davies 2015; Davies et al. 2016) . Nonetheless, within the EU, there is no mandatory programme for the control of Salmonella at pork primary production level. The European Commission has considered the measures that could be applied in order to reduce the Salmonella prevalence in pigs across the member states, and it is likely that successful control will include effective preharvest actions in breeding herds (Andres and Davies 2015) . The EU was originally expected to introduce regulations concerning the monitoring and control of Salmonella in pigs after an initial focus on the control of Salmonella in poultry, although proposals were dropped following a negative cost-benefit analysis (DGSANCO, http://ec.europa.eu/food/food/biosafety/sa lmonella/docs/fattening_pigs_analysis_costs.pdf; accessed 10/02/2017). However, despite enhanced hygiene interventions at slaughter, the control of Salmonella carriage and shedding remains a challenge in most countries (Davies et al. 2016) .
The persistent and frequently asymptomatic nature of porcine Salmonella infection and the organism's ability to colonize other animal species, such as rodents and wild birds on farms, and to survive in the environment means that effective control generally requires multiple measures (Wales and Davies 2017) . In summary, control measures against Salmonella infection can be divided into five broad interventions: biosecurity, feed management, acidification of feed or water, manipulation of gut microbiota and vaccination (Andres and Davies 2015; Wilhelm et al. 2016) . Wilhelm et al. (2016) suggest that biosecurity and vaccination seem to be the intervention categories showing the greatest potential to minimize Salmonella on an infected farm, and only culling of infected pigs can totally eliminate infection. However, in most countries, a source of Salmonella-free replacement pigs is not available and the risk of re-infection is high (Wales and Davies 2017) .
It is generally accepted that vaccination can play a role in reducing the prevalence of Salmonella in pigs and could become an adjunct to other on-farm control measures (Denagamage et al. 2007 ) by helping to prevent Salmonella colonizing the gut and reducing the subsequent shedding and development of a carrier state (Haesebrouck et al. 2004) . Several candidate vaccines for Salmonella in pigs have been developed, from inactivated bacterins to elicit a humoral response to live or adjuvanted vaccines that additionally stimulate cell-mediated immunity (Davies et al. 2016) . Live vaccines theoretically offer the best option, since they are able to stimulate cellmediated immunity (Mastroeni et al. 2001; Haesebrouck et al. 2004) , but the extent of this may be limited by the attenuation process necessary for licensing, with the vaccine being cleared from the body before slaughter of pigs and nonpersistent in the environment. Vaccination strategies that involve stimulating both passive immunity from the dam (sow vaccination) plus active immunity in offspring (piglet vaccination) appear to be most efficacious, although either approach alone can yield significant control of Salmonella (Wales and Davies 2017) . Relatively few vaccination studies with Salmonella have been undertaken under field conditions on pig farms and most of these have been conducted with small numbers of animals (Schwarz et al. 2011; Arguello et al. 2013; De Ridder et al. 2014; Ruggeri et al. 2015; Davies et al. 2016) . Several studies have evaluated live vaccines for Salmonella Choleraesuis, a serovar that is particularly pathogenic to both pigs and some humans (Schwarz et al. 2011) , but is now rarely reported in Europe (EFSA 2016, Wales and Davies 2017) . The remaining studies have tested an attenuated vaccine for ST. Monophasic variants of S. Typhimurium (mST) (S. 1,4,[5] ,12:i-and S. 1,4,12:i-) have emerged as a public health threat, and ST and mST are the second and third most frequently isolated serovars from human cases of salmonellosis in Europe, representing 15Á8 and 8Á3% respectively, of 69 663 confirmed human cases in 2015 (EFSA 2016) . These vaccination studies found a reduction of faecal shedding by fattening pigs (Arguello et al. 2013; De Ridder et al. 2014) . When sows plus piglets were vaccinated, a consistent reduction in shedding was observed, but results were more variable and lacked statistical significance (Ruggeri et al. 2015) .
Recently, Davies et al. (2016) examined the immunization of sows in three farms with follow-up of the breeding and rearing animals for up to 2 years after the initial prevaccination visit. Although the study provided sustained reductions in Salmonella Typhimurium and mST-shedding among pigs up to slaughter age, it was based on an observational study under field conditions, which was uncontrolled. Longitudinal field studies examining natural infections are comparatively uncommon among reports of Salmonella vaccination trials in pigs (Davies et al. 2016) . In this study, we developed a long-term longitudinal field study to evaluate the efficacy of vaccination with an inactivated ST vaccine to all breeding sows present in the herd as a strategy to reduce the prevalence of Salmonella infection in farms with a salmonellosis problem.
Materials and methods

Farms
A total of 35 farms were invited to participate in the study in order to find 16 eligible and willing participants. Farms were selected based on the following inclusion criteria: (i) indoor breeder-finisher enterprise, (ii) herd size of 100-600 sows, (iii) a recent occurrence of ST or mST, (iv) presence of ST or mST in finishing pigs, (v) farmer willing to be involved for the entire study period and (vi) sows free of significant clinical disease which may have affected the efficacy of the vaccine.
Sampling visits and vaccination schedule
Farms were randomized into vaccinated (n = 8) and nonvaccinated groups (n = 8, recorded as control farms from this point on). Farms were followed for approximately 69 weeks after the start of the trial, with four sampling visits (details of the study design are summarized in Table 1 ). Sows were vaccinated with a live attenuated vaccine by subcutaneous injection (Salmoporc STM; IDT Biologika GmbH, Dessau-Rosslau, Germany). Vaccine was administered to prepartum sows (6 and 3 weeks ante-partum) with a single booster dose 3 weeks before each subsequent farrowing. The first dose was given to the first batch of sows in week 1 and the second dose in week 4. The piglets (progeny) from the first batch of vaccine sows were estimated to go to slaughter during week 33. The last batch of sows was vaccinated in weeks 23 and 26 and farrowed in week 29, with their progeny going to slaughter in week 55. Sampling visits took place prior to vaccination (week 0); at a point where half of the progeny on the farm were estimated to come from vaccinated sows (week 21); when all of the finishers on the farm came from vaccinated sows (week 55); and a final 'follow-up' sampling visit took place up to 3-4 months after all of the finishers on the farm came from vaccinated sows (week 69). Sows were observed closely for any signs of ill health after vaccination.
Sampling and Salmonella detection
A target of 60 individual floor faeces samples were collected at each visit from each of the following pig stages: weaners, growers and finishers, providing a 95% probability of detection assuming a 5% prevalence and 100% sensitivity of detection (EpiTools epidemiological calculators; Ausvet Pty Ltd, Bruce, ACT, Australia). Faeces were collected in sterile stool sample tubes using an integral spoon. In addition, pooled pen faeces samples (one or two pools per pen according to the number of pigs in the pen) were taken from the following pig stages: gestation, farrowing, weaners, growers, finishers and a combination of dry sows, gilts and boars. For each pig stage, up to a maximum of 20 samples were collected per building and 60 per pig stage to ensure effective detection of Salmonella prevalence and diversity of serovars across the farm. Samples were collected using a sterile gauze swab held with a clean disposable glove for each sample. In addition, wildlife and environmental samples were collected. Solid and semisolid material (up to 25 g) was collected using sterile gauze swabs, while surfaces were wiped in a zigzag path over a 2-m area with gauze swabs that had been preautoclaved in buffered peptone water (BPW), whereas 50 ml was collected from water samples. Materials and areas sampled included rodent faeces and (occasionally) carcases; wild bird faeces; flies; cleaned and empty pens and farrowing crates; pooled water sources, feed barrows and dust from feed handling areas; piglet transporters; handling facilities; manure heaps and associated run-off; vehicles, trailers, loader buckets and scrapers.
Samples were transported to the testing laboratory on the day of collection. Material was cultured for Salmonella either immediately upon arrival (pooled faeces and swabs in BPW) or after overnight storage at 4°C (individual faeces samples), using a modification of the ISO 6579:2002 (Annex D) method, as described previously (Martelli et al. 2014) . Briefly, all pooled faeces samples (approximately 25 g) and swabs were pre-enriched in 225 ml BPW at 37°C for 18 h followed by enrichment in Modified Semi-Solid Rappaport-Vassiliadis medium for Pigs from first farrowing of 1st batch of sows go to slaughter 46
Pre-3rd farrowing booster to 1st batch of sows 47
Booster vaccination of last batch of sows (3 weeks prior to 2nd farrowing) 49
Third farrowing, 1st batch of sows 50
Second farrowing of last batch of sows 54
Pigs from 2nd farrowing of first batch of sows go to slaughter 55 2nd mid study sampling (all finishers on farm from vaccinated sows) Pigs from 1st farrowing of last batch of sows go to slaughter
Full set of animal samples Environmental samples 68
Booster vaccination of last batch of sows (3 weeks prior to 3rd farrowing) 69
Final sampling visit Full set of animal samples Environmental samples 24 and 48 h at 41Á5°C then plating on Rambach agar which was incubated for 24 h at 37°C. Subsamples (2 g) of individual pig faeces samples were pre-enriched in 20 ml BPW and cultured as above. The residue of the individual pig faeces samples were stored unprocessed at 4°C. For individual faeces samples that proved Salmonella-positive, a subset of the stored material representative of positive samples from each farm, building and epidemiological group sampled was subjected to a semiquantitative enumeration procedure by creating a decimal dilution series in BPW immediately before pre-enrichment, as described elsewhere (Wales et al. 2006) . A selection (all isolates from pooled samples and any individual sample that was cultured semi-quantitatively) of Salmonella isolates were fully sero-and phage-typed in the APHA Salmonella reference laboratory using standard methodology (Jones et al. 2000) .
Herd performance/clinical salmonellosis
Herd performance data were collected at the start of the vaccination programme and at the end of the study. The parameters collected included piglets born, sow replacement rate, mortality and feed conversion rate. Details were collected on whether the farm's veterinary practitioner had identified clinical salmonellosis in the pigs since the last sampling visit, which was used to assess whether vaccination may have reduced the number of farms showing clinical symptoms in comparison to those in the control farms.
Statistical analyses
The prevalence of Salmonella in faecal (pooled and individual) and environmental samples at each visit was analysed in a generalized linear model using experimental groups (vaccine and control) as a fixed effect, within each visit. This statistical analysis was performed using SPSS (ver. 21.0) software. All subsequent analyses were performed in Stata 12 (StataCorp, 2011; Stata Statistical Software: Release 12, College Station, TX: Stata-Corp LP). A P-value of <0Á05 was considered to indicate a statistically significant difference.
For overall analysis of the effect of vaccination, a mixedeffects logistic regression model was used, to examine the association between time from the start of vaccination (represented by visit number, with the first visit being before the introduction of vaccination) and the odds of a sample being Salmonella-positive, the hypothesis being that vaccination would progressively reduce the odds of a sample being positive over time. The a priori variables were pig stage from which the sample was collected (named Pig type), sample type (individual or pooled), season (winter (December-February), spring (March-May), summer (June-August) and autumn (September-November)). The farm study identifier was added as a random effect to account for the nonindependence of sample results from the same farm. The use of farm and group random effects were tested, but the addition of group did not significantly improve the fit of the model (likelihood ratio test). An interaction term, including visit number and experimental group, was added to allow for different effects of the vaccine over visits on the different farms. Two outcomes were tested in the model: Salmonella-positive or ST/mSTpositive.
A paired T-test was used to compare herd performance at the initial visit of the vaccination programme (visit 1) and at the final visit (visit 4) for vaccine and control groups.
Results
From 35 farms invited to participate in the study, six farms were not eligible as no ST/mST was detected from 20 pen faecal swab collected from the farm to confirm status prior to the start of the study. A further seven farms were rejected due to complex multi-site operations which would have limited the ability to trace the vaccine effect in finishers. Three farms had an ineligible farm type and one farm was too small. In addition, two farms had started vaccination programmes, but were discarded as it was not possible to provide a baseline situation. Therefore, data from 16 farms are presented in this study. From the eight farms in the vaccine group, five farms employed a weekly batch sow management system and the others three farms, employed a 2-, 3-and 4-week batch system, respectively. In the control group, seven farms used a weekly batch management system and one farm employed a 3-week batch system. Two of the control farms used dairy by-products in their feed, while two used acidified water and one acidified feed, whereas two vaccinated farms used fermented liquid feed with dairy by-products and one used acidified water. The mean number of sow and gilts per herd was 321 (range from 150 to 550) for vaccine farms and 406 (range from 150 to 750) for control farms. Clinical problems (diarrhoea, septicaemia, ill-thrift and increased mortality), associated with Salmonella infections, were reported from six vaccine and three control farms, respectively. ST/mST serovars had been detected in weaned pigs on all farms before the start of the trial.
Bacteriological results
A total of 22 246 samples (9747 pooled faeces samples, 10 905 individual faeces samples and 1594 environmental samples) were collected between April 2014 and May 2016, with an intense level of sampling per visit (mean of 374 samples collected in each visit). The environmental samples were mainly from run-off/water puddles (288 samples); waste handling equipment (284) and wildlife faeces (208), with the highest prevalence detected in walkways (55Á2%, 134 samples), run-off/ water puddles (50Á3%) and waste handling equipment (48Á2%) and the lowest from water (5Á8%, 52 samples) and feed sources (14Á2%, 120 samples). Bacteriological findings from faeces samples are summarized in Table 2 . The initial visit (visit 1) results demonstrated a similar high prevalence of Salmonella from faeces samples in both vaccine and control groups; 30Á8 vs 36Á2% of pooled samples, 19Á1 vs 21Á9% of individual samples, and 34Á6 vs 53Á0% of environmental samples, for vaccine vs control groups, respectively. The proportion of Salmonella-positive samples ranged from 3Á7 to 62Á2% on vaccine farms and from 11Á5 to 67Á0% on control farms in pooled samples. Prevalence of ST/mST, which represented more than 90% of all Salmonella isolates, was also high at visit 1 in both experimental groups. At the second and third visits, following the start of the vaccination programme, reduction in prevalence of Salmonella and ST/mST was not apparent in control farms. However, vaccine farms showed significantly reduced Salmonella prevalence at the final visit (Table 2 ). For pooled faecal samples, 19Á8% of vaccine farms' samples were positive for Salmonella, while 41Á0% of samples from control farms were positive (P = 0Á041). For individual faeces, 13Á4% of the vaccine farms samples were positive compared with 32Á0% of samples from the control farms (P = 0Á018). However, for environmental samples, 21Á2% of the samples from vaccinated farms were Salmonella-positive compared with 42Á8% of the control farms, which was only approaching significance (P = 0Á073) possibly due to the more limited number of samples of this collected. Vaccine farms showed reduced ST/mST prevalence at the final visit, although the comparisons were not statistically significant (Table 2) . Figure 1 summarizes the effect of sow vaccination on the Salmonella sample prevalence of pigs for all the rearing stages. Weaners and finishers born from vaccinated sows showed significantly reduced Salmonella sample positivity (P = 0Á006 and P < 0Á001, respectively). Samples from growers born from vaccinated sows also showed reduced Salmonella prevalence, although the difference was only approaching significance (P = 0Á057).
The effect of vaccination was not consistent on all farms; in one farm, prevalence increased at visit 2, and this rise was sustained up to the final visit for both pooled samples (3Á7, 35Á8, 29Á5 and 38Á5% for visits 1, 2, 3 and 4, respectively) and individual samples (0Á0, 16Á2, Table 2 Bacteriological results from the pooled and individual faecal samples and environmental samples collected on-farm for the evaluation of the protection against Salmonella Typhimurium and its monophasic variants conferred by S. Typhimurium vaccine administered to sows on eight commercial farrow-to-finish pig herds and compared with eight control farms. 26Á9 and 23Á3% for visits 1, 2, 3 and 4, respectively). Another vaccine farm showed only a slight reduction after vaccination, with a similar sample prevalence observed at visits 2 and 3 to that at the beginning of the experiment (20Á1, 8Á6, 17Á6 and 19Á3% of pooled samples for visits 1, 2, 3 and 4, respectively, and 16Á5, 12Á2, 18Á9 and 12Á4% of individual samples for visits 1, 2, 3 and 4, respectively). However, it should also be noted that although two vaccine farms retained a ST/mST prevalence of over 20% at the final visit in the pooled samples, no vaccinated farm had a prevalence of over 20% in the individual samples. Details of farm structure and management (such as flooring type and use of acidified feed) were investigated, but no apparent difference was detected that could explain the difference in treatment effect.
Findings from the mixed-effects models are summarized in Table 3 . There was a significantly decreased odds ratio of Salmonella-positive (OR = 0Á726, P < 0Á001) and ST/mST-positive samples (OR = 0Á706, P < 0Á001) for vaccine farms in comparison to control farms and that samples collected at visit 2 where at significantly lower odds for both outcomes than at the first visit. Examining the interaction between the experimental groups and visit number showed that there was a significantly decreased odds ratio of Salmonella-positive (OR = 0Á512, P < 0Á001) or ST/mST-positive (OR = 0Á613, P < 0Á001) at visit 4 for vaccine farms only. The analysis of the sample type on all the farms revealed a significant increased odds of isolation in pooled samples of Salmonella (OR = 2Á697, P < 0Á001) and ST/mST (OR = 2Á558, P < 0Á001). There was a significantly increased odds of isolation in summer of Salmonella (OR = 1Á214, P = 0Á004) or ST/mST (OR = 1Á198, P = 0Á013) and an increase in Spring and Autumn for ST/mST-positive (OR = 1Á119, P = 0Á025 and OR = 1Á130, P = 0Á047) when compared with Winter. Finally, the model showed significantly increased odds (P < 0Á001) of Salmonellapositive and ST/mST-positive samples for all pig group types (except boars) and significantly reduced odds of both the outcomes for farrowing groups, when compared against the gestation group, with weaners presenting with the highest odds of detection.
The results of Salmonella enumeration in faecal samples across the trial are shown in Table 4 . No apparent significant effect of vaccination was detected on Salmonella concentration in the faecal samples.
Although farms were selected because of significant occurrence of ST/mST and these serovars dominated (more than 90%), a total of 23 different Salmonella serovars were identified over the entire period of the study. Nevertheless, 19 serovars represented <1% of positive samples (data not shown). Non-ST/mST isolates were mainly confined to serovars S. Kedougou (5Á9%) and S. Derby (1Á8%).
Herd performance
The herd performance results from the first and final visits are shown in Table 5 . In summary, although some differences were shown suggesting that vaccination had a positive effect, such as for average daily live-weight gain and feed conversion ratio, the results did not show a statistically significant influence. By the final visit, only one of the original six vaccine farms (17%) reporting clinical symptoms were still presenting with clinical cases, in comparison with one of the three (33%) controls.
Discussion
This study is the first extensive controlled study of its kind to demonstrate that the strategy of maternal vaccination against Salmonella Typhimurium is able to reduce, in a substantial proportion of treated farms, both faecal and environmental prevalence of Salmonella in farrowto-finish pig herds, especially for serovars ST and its monophasic variants. Nevertheless, according to previous studies, although a beneficial association between vaccination and Salmonella reduction was observed, vaccination strategies alone are not sufficient to eliminate infection that is present on pig farms and all vaccines aimed at intestinal bacteria should preferably be applied to uninfected animals on a preventative basis rather than in the face of infection (Wales et al. 2011; Soumpasis et al. 2012) . The persistent and frequently asymptomatic nature of porcine Salmonella infection and the organism's abilities to colonize other animal species and to survive in the environment mean that effective control of subclinical Salmonella infection generally requires multiple approaches applied simultaneously, although clinical salmonellosis can usually be markedly improved by vaccination alone, as demonstrated in the current study (Wilhelm et al. 2016; Wales and Davies 2017) . Vaccination may assist in the protection of animal health, reduction of antibiotic usage, enhancement of food safety as well as reduction of economic losses and environmental contamination associated with faecal waste and run-off and transmission of Salmonella to other food animal species, such as poultry, by wildlife vectors (Andr es-Barranco et al. 2014; Bearson et al. 2016) .
Vaccination is the second most frequently studied onfarm intervention measure for Salmonella control (Wilhelm et al. 2016 ). However, longitudinal field studies (such as the present one) examining natural infections are uncommon among pig trials (Davies et al. 2016; Wilhelm et al. 2016) . This study was novel in that the trial 
N: total number of samples.
was run under controlled field conditions, using a large number of studied animals, and focusing on farms with an existing Salmonella problem. Although direct comparison with previous studies must be applied carefully owing to inherent experimental differences (Ruggeri et al. 2015; Davies et al. 2016) , our results confirm that vaccination of sows can reduce the prevalence of Salmonella in farrow-to-finish pig herds. In addition, these results highlight an important reduction in contamination in the farm environment.
There are a number of strategies that may be used when implementing vaccination of pigs against Salmonella (Wales and Davies 2017) . For instance, immunization of sows to protect their offspring (Roesler et al. 2006; Ruggeri et al. 2015; Davies et al. 2016) or vaccination early in the pig's life (Hur and Lee 2010; Schwarz et al. 2011; De Ridder et al. 2014; Ruggeri et al. 2015) , during suckling (Hur et al. 2001) , after weaning (Berends et al. 1996; Kranker et al. 2003; Merialdi et al. 2008) or during fattening (Arguello et al. 2013) . It has been previously reported that when sows were vaccinated, the prevalence of Salmonella shedders, as well as the prevalence of seropositive pigs within the progeny, was reduced and it was suggested that vaccination of breeding sows could be an easy-to-apply and economic way to reduce Salmonella transmission to progeny and enhance maternal immunity. Vaccinating the piglets would have required a much larger number of doses and a greater labour cost in dosing litters and weaners. Other studies have suggested that additional vaccination of suckling piglets and weaners would provide further benefits, but this is less easy and economical to carry out in many farming systems (Roesler et al. 2006; Andres and Davies 2015; Ruggeri et al. 2015) . Vaccinal protection of sows is particularly relevant in farrow-to-finish pig herds where breeders and finishing pigs are housed in the same environment and weaned pigs present a continuous source of environmental contamination with ST or mST (Lurette et al. 2009 ). The carriage of Salmonella by piglets is readily demonstrated from the farrowing accommodation onwards (Jones et al. 2000) . According to Kranker et al. (2003) , Salmonella is predominant in weaners, growers and finishers. Nevertheless, once all sows were vaccinated, a reduction in Salmonella prevalence was observed in all these stages of pig production, and mainly in finishers, hence reducing the total Salmonella burden before slaughter, at the beginning of the pork-based food chain. The reduction in shedding by growing pigs on the farrow-tofinish pig herds is also consistent with enhanced passive immunity, clearance of infection and reduced carriage of infection by weaners, eventually maturing into growers and finishers (Davies et al. 2016) . Although previous findings have also shown that pigs born from vaccinated sows have reduced Salmonella faecal shedding (Roesler et al. 2006; Matiasovic et al. 2013) , the reduction in environmental contamination and re-cycling of infection is also important (Davies et al. 2016) . Collectively, our data suggest that maternal vaccination can significantly reduce carriage of Salmonella in the progeny of vaccinated pigs, as well as environmental contamination.
However, the Salmonella prevalence reduction observed in the vaccinated farms was not observed in all herds, and this is consistent with other studies. De Ridder et al. (2014) observed response variability after oral vaccination of piglets with the same product on three farrow-to-finish pig herds. In our study, vaccination did not have a marked effect on faecal or environmental prevalence of Salmonella on two herds. Importantly, in these herds, clinical salmonellosis had been reported before the start of the vaccination programme, which may have represented a recent outbreak caused by a new strain being introduced to a naive population and presenting an overwhelming challenge for the vaccine within the timescale of the study. In both of these herds, staff reported that clinical salmonellosis symptoms were not seen following the start of vaccination. It is known that live attenuated Salmonella Typhimurium vaccines can help prevent clinical salmonellosis, reducing tissue colonization and faecal shedding (Roesler et al. 2004; Gradassi et al. 2013) , and the results show that a larger proportion of vaccinated farms had ceased to show clinical signs in comparison to the controls. In one of these herds, the highest prevalence occurred in the later stages of pig production, and the highest concentrations of Salmonella in faeces were reported on this farm, indicating possible nonoptimal management of grower and finisher pigs and persistent contamination of their accommodation. In the other herd, no effect after vaccination was observed throughout the study. Each pig farm is unique in terms of location, facilities, management, host susceptibility and other influential factors (Andres and Davies 2015) , and there are several plausible possible explanations for the variability in the vaccine effect. Under field conditions, pigs are infected at different points in time, with a herd-dependent and even batch-dependent variability in both infection pressure and host response (Beloeil et al. 2003; Rostagno and Callaway 2012; Lo Fo Wong et al. 2014) . Similarly, the presence of herd-specific S. enterica strains might have affected the impact of vaccination (Van Parys et al. 2013 ). There may also have been interactions, whereby vaccination may not have been effective if threshold levels of farm risk factors control were not achieved, resulting in a high level of environmental contamination or risk of transmission of infection between batches of pigs (Davies et al. 2016) . As an example of natural variability, a significant reduction in Salmonella prevalence was observed in one control farm. It should be noted that this farm had the second lowest prevalence level of all farms at the beginning of the study. A plausible explanation may be that existing farm hygiene and biosecurity controls were being better implemented and maintained or that the management systems in place involved exposure to infection at times that could maximize the development of natural herd immunity (Knetter et al. 2015; Davies et al. 2016) , or some farm-resident strains may theoretically lose virulence over time (Hayden et al. 2016) . The study findings demonstrate that it is reasonable to postulate that maternal vaccination strategy at least contributed to the observed improvements in Salmonella control, especially since these farms did not apply any other interventions during the study period. The validity of the findings is supported by the fact that pooled faecal samples, individual faecal samples and environmental sample presented with similar reductions in Salmonella positivity. Additionally, pooled pen faecal samples are highly sensitive and the culture method used can identify small numbers of organisms and low within-group Salmonella prevalence, thus maximizing detection (FedorkaCray et al. 2000; Arnold and Cook 2009) . A less sensitive sampling and detection method may have resulted in more apparently negative samples and therefore a greater apparent vaccinal effect.
Salmonella counts in representative positive faeces selected for quantification were similar between nonvaccinating and vaccination herds. Due to the limited amount of enumerated samples, statistical comparisons were restricted. In another field study, Davies et al. (2016) reported a reduction in Salmonella counts in faeces from the pigs born to vaccinated dams. In an experimental trial, Jordan et al. (2013) also reported a reduction in Salmonella counts 20 days after vaccine administration in growing pigs. More research is required to fully elucidate the impact of vaccination on Salmonella counts in faeces.
Although 23 different serovars were isolated, many of these were likely to have been transient. In fact in this study, the significant reduction in isolation of 'all salmonellas' over time predominantly reflects the reduction in ST and monophasic variants as these represented most of the isolates. Studies have shown that current vaccines provide limited cross-protection against nontarget serovars (Wallis 2001; Foss et al. 2013; Bearson et al. 2016) , although some studies reporting that vaccination against S. Choleraesuis can cross-protect pigs against ST (Nnalue and Stocker 1987; Maes et al. 2001) . As ST and mST are serovars that pose the largest risk to humans within the UK pig reservoir, it is of most importance that these could be controlled by using the vaccine evaluated in this study, especially when combined with good biosecurity, management and farm hygiene practices (Andres and Davies 2015) .
Potential economic benefits could be achieved through better herd performance, for example, by reducing salmonellosis and the need to medicate pigs at weaning, improving feed conversion efficiency and daily live-weight gain (Andres and Davies 2015) . In this context, previous studies have demonstrated average daily gain benefits as a result of vaccination of preweaned piglets (Farzan and Friendship 2010; De Ridder et al. 2014) . In contrast, Husa et al. (2009) , in an experimental trial, reported that the growth rate was lower in piglets vaccinated with a commercial S. Choleraesuis/ST live vaccine than in unvaccinated piglets due to adverse reactions after vaccination, but the vaccine was protective against subsequent challenge. In our study, vaccination did not have any significant effect on piglet and sow performance, as reported by the farmers' farm records, but this was not independently measured. In a similar experimental design (piglets born from vaccinated sows), Ruggeri et al. (2015) showed a beneficial effect on the average daily live-weight gain, although the differences also did not reach statistical significance. De Ridder et al. (2014) also found that oral vaccination of piglets was associated with improved daily live-weight gain in experimentally infected pigs and suggested that feed conversion efficiency may have been improved. It is likely that Salmonella infection depressed the appetite of the nonvaccinated study pigs, but significant improvements in growth parameters were not observed in the current study. In future studies, collecting data at a lower resolution (e.g. pen or building level) may help provide an adequate population to analyse the effect.
Our results provide evidence that maternal vaccination on a farrow-to-finish pig herd was a suitable ST/mST reduction strategy and helped to control clinical salmonellosis. Salmonella vaccines, therefore, have the potential to reduce prevalence of Salmonella in pigs and result in a reduction of human cases attributed to pork. However, more research is required to qualify the impact throughout the pig meat production chain.
